ATS 2020 Advance Program

1:00 Ventilator Dyssynchrony Results of the Reevaluation of Systemic Early Neuromuscular Blockade (ROSE) Trial J.R. Beitler, MD, MPH, New York, NY 1:10 Questions and Answers L. Reineck, MD, Bethesda, MD AMERICAN LUNG ASSOCIATION L20 AMERICAN LUNG ASSOCIATION AIRWAYS CLINICAL RESEARCH CENTERS LUNG HEALTH COHORT STUDY 12:15 p.m. - 1:15 p.m. Target Audience Physicians, clinical scientists, nurses, paraprofessionals, educators, health care providers Objectives At the conclusion of this session, the participant will be able to: • apply emerging concepts of respiratory health to both clinical and research settings; • learn new findings about the participation of millennials in research studies and how to recruit this unique generation in longitudinal research studies; • improve the understanding of the current environmental influences on respiratory health in the 21st century and how early lung injury becomes clinically apparent on lung imaging studies. Pulmonary physicians and respiratory researchers define respiratory health as the absence of lung disease. Intermediate phenotypes of impaired lung health are not well-defined because of the absence of adult life-course studies focused primarily on lung health. There is a critical need to identify modifiable risk factors and biomarkers for impaired lung health to allow clinicians to recognize impaired lung health and intervene before chronic lung disease develops. The ALA ACRC Lung Health Cohort will form the first national cohort of adults focused on respiratory health. This session highlights the Lung Health Cohort, its rationale, recruitment strategy, key measurements and outcomes. Chairing: W.C. Bailey, MD, Birmingham, AL R.A. Wise, MD, Baltimore, MD 12:15 Defining Respiratory Health R. Kalhan, MD, MS, Chicago, IL 12:27 Recruitment and Retention of the ALA Lung Health Cohort: A New Focus on Millenials M. Carnethon, PhD, Chicago, IL 12:39 Lung Imaging in Epidemiologic Studies: Applications to Lung Health G.R. Washko, MD, Boston, MA 12:51 Environmental Exposures and Lung Health: The 21st Century Exposome M.B. Rice, MD, MPH, Boston, MA 1:03 Discussion MEET THE PROFESSOR SEMINARS Registration Fee: $70.00 (includes box lunch.) Attendance is limited. Pre-registration is required . 12:15 p.m. - 1:15 p.m. MP501 MECHANISMS OF ASPIRIN DESENSITIZATION W. Stevens, MD, PhD, Chicago, IL K. Cahill, MD, Nashville, TN MP502 MOTIVATIONAL INTERVIEWING TO IMPROVE ADHERENCE TO ASTHMA THERAPY A. Weinstein, MD, Rockland, DE H. Tapp, PhD, Charlotte, NC MP503 CYSTIC LUNG DISEASE: UNCOMMON DISORDERS COMMONLY MISDIAGNOSED R.M. Kotloff, MD, Cleveland, OH MP504 TOLERATING UNCERTAINTY: CHANGING THE MINDSET OF DOCTORS AND PATIENTS R.M. Schwartzstein, MD, Boston, MA MP505 DEADSPACE, AIRSPACE, HEADSPACE OR OTHER: A CPET TOUR OF DYSPNEA J.S. Fritz, MD, Philadelphia, PA MP506 LUNG TRANSPLANT IN IPF: WHY, WHEN AND HOW? N. Patel, MD, Philadelphia, PA ATS 2020 • Philadelphia, PA 84 MONDAY • MAY 18